Accumbens shell mu-opioid signaling in alcohol self-administration and relapse

伏隔壳 mu-阿片类信号传导在酒精自我给药和复发中的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): A large body of evidence points to the importance of endogenous opioids in alcohol drinking and reinforcement (1). The medial shell of nucleus accumbens (NAc) has emerged as an important neural substrate for these effects and may mediate problem alcohol use (2-9). Importantly, infusion of the mu-opioid receptor agonist, DAMGO, into rodent NAc potentiates alcohol consumption (10), yet the behavioral and neurological mechanisms of this effect remain unknown. Medial NAc shell is a critical relay for prefrontal cortical influences on both hypothalamus and ventral pallidum, forming an "extinction circuit" which may co -opt mechanisms normally devoted to satiety, and modulation of this circuit may serve as a critical mechanism of opioid-induced alcohol consumption and relapse (11-12). Glutamatergic inputs from infralimbic cortex to medial NAc shell are posited to suppress drug and alcohol seeking following extinction and during reinstatement (13- 14), potentially via inhibitory projections from NAc to ventral pallidum and lateral hypothalamus (11, 15). The proposed experiments will systemically test the psychological and neural mechanisms of NAc DAMGO- induced alcohol consumption, and in particular the effects of NAc shell DAMGO on this extinction circuit. The experiments in Aim 1 of this proposal will test the specific effects o NAc shell DAMGO in alcohol self - administration and cue-induced relapse to alcohol seeking, to determine what aspects of alcohol reward are enhanced by NAc mu-opioid signaling (i.e. palatability, motivation, or reinforcement). It is critical to understand how NAc shell mu-opioid signaling affects top-down inputs from infralimbic cortex that may normally suppress alcohol seeking and relapse. Aim 2 of the research plan will test whether selective activation of infralimbic inputs to NAc can suppress alcohol consumption and relapse, and whether NAc shell DAMGO blocks these effects, during alcohol self-administration and relapse. It is also vital to understand how NAc mu-opioid induced changes in alcohol seeking are encoded in downstream structures of the extinction circuit, including ventral pallidum and lateral hypothalamus, which may encode different aspects of alcohol reward. The experiments in Aim 3 will test whether neural activity in lateral hypothalamus or ventral pallidum encodes alcohol seeking, consumption, or relapse to alcohol seeking, or enhancements in any of these processes following NAc shell DAMGO.
描述(由申请人提供):大量证据表明内源性阿片类药物在饮酒和强化中的重要性(1)。伏隔核(NAc)的内侧壳已成为这些影响的重要神经基质,并可能介导酒精使用问题(2-9)。重要的是,在啮齿类动物NAc中注入mu-阿片受体激动剂DAMGO可增强酒精消耗(10),但这种作用的行为和神经机制尚不清楚。内侧NAc壳是前额叶皮质对下丘脑和腹侧白质影响的关键中转,形成一个“消退回路”,可能会参与通常用于饱腹感的机制,该回路的调节可能是阿片类药物诱导的酒精消耗和复发的关键机制(11-12)。从边缘下皮层到内侧NAc壳的谷氨酸能输入被认为在消失后和恢复期间抑制药物和酒精寻求(13- 14),可能是通过NAc到腹侧白球和外侧下丘脑的抑制投射(11,15)。本实验将系统地测试NAc DAMGO诱导饮酒的心理和神经机制,特别是NAc外壳DAMGO对这种消光回路的影响。本研究的目的1中的实验将测试NAc壳DAMGO在酒精自我给药和线索诱导的酒精寻求复发中的特定作用,以确定NAc -阿片样物质信号增强了酒精奖励的哪些方面(即可接受性、动机或强化)。了解NAc外壳mu-阿片样物质信号如何影响边缘下皮层自上而下的输入是至关重要的,这些输入通常可能抑制酒精寻求和复发。研究计划的目的2将测试在酒精自我给药和复发期间,对NAc的边缘下输入的选择性激活是否可以抑制酒精消耗和复发,以及NAc壳DAMGO是否阻断这些作用。了解NAc - muopioid诱导的酒精寻求变化是如何在消退回路的下游结构中编码的也是至关重要的,包括腹侧苍白球和外侧下丘脑,它们可能编码酒精奖励的不同方面。Aim 3的实验将测试下丘脑外侧或腹侧苍白球的神经活动是否编码酒精寻求、消费或酒精寻求复发,或NAc壳DAMGO后这些过程中的任何一种增强。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jocelyn M Richard其他文献

Jocelyn M Richard的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jocelyn M Richard', 18)}}的其他基金

Neural basis of incentive and expected value representations
激励和期望值表示的神经基础
  • 批准号:
    10578757
  • 财政年份:
    2022
  • 资助金额:
    $ 4.71万
  • 项目类别:
Neural basis of incentive and expected value representations
激励和期望值表示的神经基础
  • 批准号:
    10363470
  • 财政年份:
    2022
  • 资助金额:
    $ 4.71万
  • 项目类别:
Glutamatergic basal forebrain neurons in aversion-resistant drinking
厌恶性饮酒中的谷氨酸能基底前脑神经元
  • 批准号:
    10337220
  • 财政年份:
    2021
  • 资助金额:
    $ 4.71万
  • 项目类别:
Glutamatergic basal forebrain neurons in aversion-resistant drinking
厌恶性饮酒中的谷氨酸能基底前脑神经元
  • 批准号:
    10094944
  • 财政年份:
    2021
  • 资助金额:
    $ 4.71万
  • 项目类别:
Glutamatergic basal forebrain neurons in aversion-resistant drinking
厌恶性饮酒中的谷氨酸能基底前脑神经元
  • 批准号:
    10555313
  • 财政年份:
    2021
  • 资助金额:
    $ 4.71万
  • 项目类别:
Ventral pallidal circuitry in alcohol seeking and reinstatement by stress
寻找酒精和压力恢复的腹侧苍白球回路
  • 批准号:
    9385558
  • 财政年份:
    2017
  • 资助金额:
    $ 4.71万
  • 项目类别:
Mesocorticolimbic Generation of Motivation
中皮质边缘的动机产生
  • 批准号:
    8267544
  • 财政年份:
    2010
  • 资助金额:
    $ 4.71万
  • 项目类别:
Mesocorticolimbic Generation of Motivation
中皮质边缘的动机产生
  • 批准号:
    8118286
  • 财政年份:
    2010
  • 资助金额:
    $ 4.71万
  • 项目类别:
Mesocorticolimbic Generation of Motivation
中皮质边缘的动机产生
  • 批准号:
    7905506
  • 财政年份:
    2010
  • 资助金额:
    $ 4.71万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 4.71万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 4.71万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 4.71万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 4.71万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 4.71万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 4.71万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 4.71万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 4.71万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 4.71万
  • 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
  • 批准号:
    10534864
  • 财政年份:
    2023
  • 资助金额:
    $ 4.71万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了